explore -WSS

explore

author：Wikipedia 2025-10-01 18:47:22 - browse：8251

Adam Feuerstein, upper left, moderated a panel with, clockwise, David Chang of Allogene Therapeutics, Rachel Haurwitz of Caribou Biosciences, and Lynelle Hoch of Bristol Myers Squibb. STAT

If you ask biopharma leaders what’s ahead for CAR-T cancer therapy, they say the future is bright. And that future will also look markedly different than it does today, three of them said at the STAT 2023 Future Summit on Wednesday.

Now in its second decade, the cell therapy — which attacks cancer by extracting white blood cells from a patient, genetically modifying them, and then re-infusing them to fight the cancer — has made remarkable strides. Biotech reporter Adam Feuerstein reminded panelists that Emily Whitehead, the first pediatric patient to receive the therapy at age 10, has just started college.

But for all its success in changing the lives of up to 7,000 patients to the point one can use the word “cure,” the field has been hampered by wait lists at manufacturers making these patient-specific, autologous therapies and a shortage of medical centers to administer them. Patients bear a burden, too: Training their B cells to attack their tumors requires an onerous depletion process before their cells can be taken out of their bodies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Another man arrested in connection with shooting at Kansas nightclub

focus

WSS

Readout LOUD podcast, live from the STAT Breakthrough Summit East

With Wegovy coverage, Medicare patients may face high costs

Mirador, a new biotech startup, launches with $400 million

How corporate America is slashing DEI workers amid backlash to diversity programs

Florida group launches initiative to get abortion constitutional amendment on 2024 ballot

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

focus

explore

explore

Bright Health sells Medicare Advantage business to Molina

UPS workers' union leader explains what's at stake as strike edges closer

Medical records are filled with copy

Biotech investment managers search for lucrative opportunities

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Another man arrested in connection with shooting at Kansas nightclub

Walensky prepares to leave CDC — and Congress — behind

Asbestos ban is immediate, but health effects will linger for decades

What does generative AI mean for health care? We asked experts

California man arrested in connection with serial murders of Mexican strip club workers

knowledge

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

How redistricting in 6 states could affect who controls Congress

How corporate America is slashing DEI workers amid backlash to diversity programs

'Patient friction coefficient' can gauge a clinical trial's patient burden

Trump seeks lengthy delay of classified docs trial, citing upcoming election

Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation

focus

focus

entertainment

knowledge